Navigation Links
Neutrogena(R) Dermatologics Introduces skin iD(TM), the First Personalized Acne Solution
Date:6/12/2008

Clinically proven to be 2X more effective in acne clearing, and 2X more

effective in acne prevention vs. the leading acne system

LOS ANGELES, June 12 /PRNewswire/ -- Neutrogena(R) Dermatologics, a unit of the #1 dermatologist recommended skincare brand Neutrogena(R), introduces skin iD(TM), the first personalized acne solution clinically proven to treat and prevent acne. skin iD is a precise, targeted and individualized approach to treating and preventing acne.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080612/NYTH030 )

In a clinical trial testing 500 people with different skin, acne and lifestyles, 100% of people using skin iD got clearer, healthier-looking skin. skin iD is currently the only non-prescription acne solution on the market that has conducted a double blind, randomized, placebo-controlled clinical trial -- the "gold standard" in testing methodology. This clinical trial demonstrated skin iD's power to work significantly better than the top selling acne regimen in treating 16 different signs of acne.

skin iD was developed by Neutrogena(R) Dermatologics with a group of leading dermatologists, scientists and market researchers, charged to create a customized skin-clearing solution specifically designed to treat acne on a case-by-case basis without a prescription. skin iD is comprised of a skin evaluation, an exclusive product line and a comprehensive Web site to treat each individual's acne needs.

Exclusively available on skiniD.com, and showcased through a series of infomercials, skin iD is the first proposition of its kind on the market. "We wanted to create a highly effective acne solution to meet the needs of individuals who are not satisfied with their existing acne regimen," states Jim Colleran, President, Neutrogena Corporation. "skin iD was developed with an innovative one-on-one approach. We determined that offering consumers access to skin iD through a dedicated Web site or by phone would allow for the dialogue necessary to evaluate their unique skincare needs and provide a personalized regimen."

skin iD utilizes a breakthrough skin and lifestyle evaluation tool, which contains a patent-pending algorithm that provides a personalized skincare regimen based on the specific skincare needs of each individual consumer. skin iD is formulated with two leading acne-fighting medicines, Salicylic Acid and Benzoyl Peroxide, included in more than 25 customized acne skincare regimens that cleanse, treat and protect for significantly improved skin.

To launch skin iD, Neutrogena(R) Dermatologics has enlisted singer/actress Katharine McPhee. Best known for her success on "American Idol" and her first single "Somewhere Over the Rainbow," McPhee is truly a role model for young girls, who understands the emotional impact associated with acne and the importance of finding a solution. Katharine will appear in infomercials and be featured on skiniD.com beginning in May 2008. McPhee will make her big screen debut in August, starring in "The House Bunny" opposite Anna Farris, Emma Stone and Kat Dennings for Sony Pictures.

About Neutrogena(R):

A worldwide leader in premium, dermatologist-recommended skin, hair and cosmetics products, Neutrogena(R) Corporation has been providing consumers with health and beauty improvements for over 40 years. The Company manufactures and markets a line of premium priced skin and hair care products that are distributed in more than 70 countries. Headquartered in Los Angeles, Neutrogena(R) is a subsidiary of Johnson & Johnson, world's most comprehensive and broadly based health care products company.


'/>"/>
SOURCE Neutrogena
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Update: Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador
2. Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador
3. Wolters Kluwer Health Introduces Formulary Facts(TM), a Formulary Analytics Tool that Sets the Standard for Accuracy and Ease-of-Use
4. IMTEC Introduces the SPRITE CT System
5. COSE Introduces Health Incentives, Wellness Programs for Medium-Size Businesses
6. Zebra Technologies Introduces HC100(TM) Patient I.D. Wristbanding Solution
7. PharMEDium Introduces Innovative New Admixture Label Design
8. Alaven Pharmaceutical Introduces Kit for UC Patients
9. Omron Healthcare Introduces New Device Drivers Built on Microsoft HealthVault
10. Answers From Nature Introduces 100% Non-China Ingredients for Dietary Supplements
11. Braemar Introduces the DL900 Advanced Holter Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... Linda, Ca (PRWEB) , ... June 20, 2017 ... ... of alternative polyA sites. To understand their regulatory principles, the research team developed ... mRNA-Seq, iCLIP and RNA motif analyses. This reveals at nucleotide resolution the ‘RNA ...
(Date:6/20/2017)... Fort Lauderdale, FL (PRWEB) , ... June 20, 2017 , ... ... Flex, a new scrub collection featuring seven new products designed to create tailored looks ... a mixture of polyester and cotton easy care stretch twill. , With trendy looks ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... staffing agency, recently became re-accredited by the Joint Commission, which accredits ... Commission accreditation and certification is recognized nationwide as a symbol of quality that ...
(Date:6/20/2017)... , ... June 20, 2017 , ... Uniworld Boutique ... living” aboard the line’s latest all-inclusive boutique ship, S.S. Joie de Vivre . ... built specifically for cruising France’s Seine River and designed small enough to dock directly ...
(Date:6/20/2017)... ... June 20, 2017 , ... International water ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ... world’s water crisis and how it affects the human eyes. , According ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017 Endo International plc ... 7, 2017, the Hon. Joseph R. Goodwin , ... West Virginia , entered a case ... Pelvic Repair System Products Liability Litigation (the "MDL") that ... cases to provide expert disclosures on specific causation within ...
(Date:6/3/2017)...  Eli Lilly and Company (NYSE: ... Phase 3 MONARCH 2 study showed that abemaciclib, ... combination with fulvestrant, significantly improved progression-free survival (PFS) ... with hormone-receptor-positive (HR+), human epidermal growth factor receptor ... or progressed after endocrine therapy (median PFS, 16.4 ...
(Date:5/30/2017)... 2017 Therapix Biosciences Ltd. (Nasdaq: TRPX), ... the development of cannabinoid-based drugs, today announced that ... at three upcoming scientific and investor conferences in ... Invitational: ...                     Wednesday, June ...
Breaking Medicine Technology: